JPRN-UMIN000016438
Recruiting
未知
A feasibility study of the metronomic chemotherapy using oral tegafur-uracil and cyclophosphamide for recurrent gynecological cancers - A feasibility study of the metronomic chemotherapy using for recurrent gynecological cancers
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- advance and recurrent gynecological cancer
- Sponsor
- Saitama Medical University International Medical Center
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) acute systemic inflammatory disease 2\) uncontrolled cardiovascular disease 3\) uncontrolled systemic disease 4\) double cancers
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Metronomic chemotherapy in elderly non-fit patients with aggressive B-Cell lymphomas. Phase II studyB-Cell lymphomasMedDRA version: 21.0Level: LLTClassification code 10012855Term: Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation)System Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2016-003703-62-ITFONDAZIONE ITALIANA LINFOMI ONLUS60
Active, not recruiting
Phase 1
Phase 2 trial evaluating metronomic chemotherapy in patients with relapsed or refractory Wilms tumorEUCTR2021-002540-67-FRCentre Oscar Lambret28
Recruiting
Not Applicable
Multi-parametric profiling of cancer patient samples and metronomic chemotherapy for forensic and treatment outcomes.Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteCTRI/2024/07/070026A
Active, not recruiting
Not Applicable
Study pilot of metronomic chemotherapy with ciclofosfamide, celecoxib and desametasone in patients with diagnosis of carcinoma of the refractory ormon prostate in advanced stage appraisal pharmacodynamics - PROMETORMONO REFRACTORY CARCINOMA OF PROSTATE IN ADVANCED STAGEMedDRA version: 6.1Level: PTClassification code 10007280EUCTR2005-005967-27-ITAZIENDA USL 6 LIVORNO ZONA LIVORNESE27
Completed
Not Applicable
Feasibility study of outpatient chemotherapy with S-1+CDDP in gastric cancer patientsJPRN-UMIN000002685ational Cancer Center Hospital35